JNCCN 360 - Bladder - Ongoing CE Activities

Editor:

Thomas Flaig, MD

Advertisement

Advertisement

Ongoing CE Activities

Advanced Bladder Cancer: Expert Insights on Navigating an Evolving Treatment Landscape

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care

Archived Monthly Oncology Tumor Boards: Treatment of Patients with Bladder and Upper Tract Urothelial Cancer

Breakfast with the Investigators: Urothelial Bladder Cancer

Cases from the Community: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Urothelial Bladder Cancer

Enhancing the Treatment of High-Risk Non-Muscle-Invasive Bladder Cancer With Immunotherapy-Based Regimens

Genitourinary Cancers: Assessing the Roles of Immune-Based and Targeted Therapies in a Changing Treatment Landscape

Genitourinary Cancers: Assessing the Roles of Immune-Based and Targeted Therapies in a Changing Treatment Landscape

Leveraging Expert-Informed Adverse Event Management and Supportive Care Strategies to Improve Patient Outcomes in Bladder Cancer

Oncology Today with Dr Neil Love: Management of Nonmetastatic Urothelial Bladder Cancer

Oncology Today with Dr Neil Love: Managing Metastatic Urothelial Bladder Cancer

Treatment Approaches in Early-Stage Bladder Cancer

Utilizing the Latest Evidence and Patient-Specific Factors to Individualize Treatment in Advanced Bladder Cancer

What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation in Urothelial Bladder Cancer

Sections

NCCN Resources

Copyright © 2023 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.